Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Medicinal Bioconvergence Research Center patents


Recent patent applications related to Medicinal Bioconvergence Research Center. Medicinal Bioconvergence Research Center is listed as an Agent/Assignee. Note: Medicinal Bioconvergence Research Center may have other listings under different names/spellings. We're not affiliated with Medicinal Bioconvergence Research Center, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Medicinal Bioconvergence Research Center-related inventors


Novel polypeptide having chemokine activity

The present invention relates to a novel polypeptide having chemokine activity and, more specifically, to a polypeptide composed of the amino acid sequence represented by seq id no: 1 and a use thereof. The polypeptide of the present invention is composed of seq id no: 1 and exhibits chemokine activity through the binding with ccr3, and thus, the polypeptide has a high utilization effect for various purposes, such as immunoregulation, and diagnosis, treatment, and medicine development for ccr3-mediated diseases or disease symptoms.. ... Medicinal Bioconvergence Research Center

Method for preparing novel antibody library and library prepared thereby

The present invention relates to a method for preparing a novel antibody library and a library prepared thereby. The antibody library prepared according to the present invention contains antibodies having excellent physical properties against a plurality of antigens, thereby having functional diversity and containing a plurality of unique sequences, and thus can be favorably used as an antibody library.. ... Medicinal Bioconvergence Research Center

Method for controlling cancer metastasis or cancer cell migration by modulating the cellular level of lysyl trna synthetase

The present invention relates to a novel function of lysyl trna synthetase, that is, lysyl trna synthetase interacts with 67lr through translocation of krs into plasma membrane, and so enhances tumor (or cancer) cell migration, thereby having an effect on cancer metastasis. More specifically, it relates to method for controlling cancer metastasis or cancer cell migration by modulating an cellular level of lysyl trna synthetase, an use of an expression vector comprising a construct inhibiting krs expression for preventing or treating cancer, an use of an agent inhibiting krs activity for preventing or treating cancer, a method for screening an agent which modulates cancer metastasis or cancer cell migration, a method for screening an agent inhibiting an interaction between krs and 67lr. ... Medicinal Bioconvergence Research Center

Novel lysyl trna synthetase fragment and microvesicles comprising same

The present invention relates to: a lysyl trna synthetase (krs) fragment which comprises an amino acid sequence represented by seq id no: 1 and is secreted from cancer cells; microvesicles comprising the krs fragment; and a method for providing information necessary for cancer diagnosis and screening a cancer metastasis inhibiting agent using the same. The present invention can be favorably used in the development of a diagnostic kit for providing information necessary for cancer diagnosis or the development of a cancer metastasis inhibiting agent, and thus is highly industrially applicable.. ... Medicinal Bioconvergence Research Center

Nanoparticles comprising aminoacyl trna synthetase and anticancer composition comprising same

The present invention relates to nanoparticles comprising aminoacyl trna synthetase and an anticancer composition comprising the same and, specifically, to nanoparticles which comprise glycyl-trna synthetase (grs), leucyl-trna synthetase (lrs), and isoleucyl-trna synthetase (irs), and have anticancer or immunostimulating activity; a pharmaceutical composition for preventing or treating cancer, comprising the nanoparticles as an active ingredient; a composition for immunostimulation; and a method for preparing the nanoparticles.. . ... Medicinal Bioconvergence Research Center








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Medicinal Bioconvergence Research Center in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Medicinal Bioconvergence Research Center with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###